Drug Trial Radar · NCT05282953
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
Last checked: Nov 19, 2026Latest source record: May 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Nov 10, 2022
Primary completion
Aug 10, 2023
Study completion Mar 24, 2026
Sponsor
- Lead sponsor
- Kiora Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase I/II dose-escalating study of the safety, tolerability and efficacy of KIO-301 administered intravitreally to patients with retinitis pigmentosa and choroideremia (ABACUS).
Conditions
- Retinitis Pigmentosa
- Choroideremia
- Non-Syndromic Rod-Dominant Inherited Retinal Diseases
Interventions
KIO-301Drug
KIO-301 intravitreal injection at ascending doses
Primary outcomes
What the sponsor says the trial is designed to measure.
- Main Study Primary Outcome MeasureTime frame: 84 days.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Save Sight Institute
Sydney, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Harley Eye Clinic
North Adelaide, South Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.